Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
What is the Immune System?01:38

What is the Immune System?

Overview
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beta cell reactivity defines disease-relevant pancreatic CD8 T cells in type 1 diabetes.

bioRxiv : the preprint server for biology·2026
Same author

Submicron-sized ultrasound contrast agents as therapeutic peptide delivery vehicles in type 1 diabetes.

Theranostics·2026
Same author

Differences in Clinical Manifestations and Islet Autoantibodies by Age in Adult-Onset Type 1 Diabetes.

Diabetes care·2026
Same author

Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes.

Diabetologia·2026
Same author

Identifying Insulin Autoantibodies With Differential Risk in Type 1 Diabetes With a Novel Bridging ELISA.

Diabetes·2026
Same author

Quantitative V gene-targeted T cell receptor sequencing as a biomarker in type 1 diabetes.

JCI insight·2025
Same journal

Strengthening the metabolic alliance: exercise as an essential partner of obesity pharmacotherapy.

Nature reviews. Endocrinology·2026
Same journal

Reply to 'Post-thyrotoxicosis weight gain: time to stratify and treat?'

Nature reviews. Endocrinology·2026
Same journal

Post-thyrotoxicosis weight gain: time to stratify and treat?

Nature reviews. Endocrinology·2026
Same journal

Myostatin-targeting antibody protects lean mass during incretin-induced weight loss.

Nature reviews. Endocrinology·2026
Same journal

Macronutrient mixtures and interactions in health and disease.

Nature reviews. Endocrinology·2026
Same journal

Hepatic neurons and metabolically induced liver dysfunction.

Nature reviews. Endocrinology·2026
See all related articles

Related Experiment Video

Updated: Jun 14, 2026

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
10:52

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Published on: December 17, 2010

Autoimmune polyglandular syndromes.

Aaron W Michels1, Peter A Gottlieb

  • 1Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, 1775 Aurora Court, MS B140, PO Box 6511, Aurora, CO 80045, USA.

Nature Reviews. Endocrinology
|March 24, 2010
PubMed
Summary
This summary is machine-generated.

This review explores the genetic basis of autoimmune polyglandular syndromes (APS-1, APS-2) and IPEX syndrome. It highlights how gene mutations and HLA alleles contribute to autoimmunity and loss of tolerance.

More Related Videos

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

Murine Bilateral Renal Lymphadenectomy
06:31

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

Related Experiment Videos

Last Updated: Jun 14, 2026

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
10:52

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Published on: December 17, 2010

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

Murine Bilateral Renal Lymphadenectomy
06:31

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

Area of Science:

  • Immunology
  • Genetics
  • Endocrinology

Background:

  • Autoimmune polyglandular syndromes (APS) involve multiple autoimmune diseases.
  • APS-1 is linked to AIRE gene mutations causing loss of central tolerance.
  • IPEX syndrome results from FOXP3 gene mutations in regulatory T cells.

Purpose of the Study:

  • To review the genetic underpinnings of APS-1, APS-2, and IPEX syndrome.
  • To elucidate the mechanisms of autoimmunity in these rare disorders.
  • To discuss current therapeutic strategies for autoimmune conditions.

Main Methods:

  • Review of existing literature on APS-1, APS-2, and IPEX syndrome.
  • Analysis of the genetic basis and pathogenic mechanisms.
  • Synthesis of information on current treatment approaches.

Main Results:

  • APS-1 pathogenesis involves AIRE gene mutations and impaired central tolerance.
  • IPEX syndrome is characterized by FOXP3 mutations affecting regulatory T cells.
  • APS-2 involves HLA alleles and non-HLA genes in organ-specific autoimmunity.

Conclusions:

  • Understanding rare APS and IPEX provides insights into common autoimmune diseases like APS-2.
  • Genetic factors, including HLA and non-HLA genes, play critical roles in autoimmunity.
  • Targeted therapies are being developed to manage these autoimmune disorders.